ROSE WILLIAM 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-26 4:32 pm Sale | 2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA | ROSE WILLIAM | 0 0.000% | -3,182,950 (Position Closed) | Filing |
| 2023-09-19 4:31 pm Sale | 2023-09-15 | 13D | Reata Pharmaceuticals, Inc. RETA | ROSE WILLIAM | 3,182,950 8.900% | -58,000 (-1.79%) | Filing |
| 2023-08-24 4:40 pm Unchanged | 2023-08-23 | 13D | Reata Pharmaceuticals, Inc. RETA | ROSE WILLIAM | 3,240,950 9.100% | 0 (Unchanged) | Filing |
| 2023-07-31 4:56 pm Purchase | 2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA | ROSE WILLIAM | 3,240,950 9.200% | 25,250 (+0.79%) | Filing |
| 2020-12-09 10:06 am Purchase | 2020-12-04 | 13D | Reata Pharmaceuticals, Inc. RETA | ROSE WILLIAM | 3,215,700 9.700% | 8,519 (+0.27%) | Filing |